- Home
- UTHR vs RS Comparison
UTHR vs RS Comparison
Compare UTHR & RS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- RS
- Stock Information
- Founded
- UTHR 1996
- RS 1939
- Country
- UTHR United States
- RS United States
- Employees
- UTHR N/A
- RS N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- RS Metal Fabrications
- Sector
- UTHR Health Care
- RS Industrials
- Exchange
- UTHR Nasdaq
- RS Nasdaq
- Market Cap
- UTHR 14.4B
- RS 16.1B
- IPO Year
- UTHR 1999
- RS 1994
- Fundamental
- Price
- UTHR $291.72
- RS $308.88
- Analyst Decision
- UTHR Buy
- RS Hold
- Analyst Count
- UTHR 13
- RS 4
- Target Price
- UTHR $393.08
- RS $332.67
- AVG Volume (30 Days)
- UTHR 690.9K
- RS 375.0K
- Earning Date
- UTHR 07-30-2025
- RS 07-24-2025
- Dividend Yield
- UTHR N/A
- RS 1.55%
- EPS Growth
- UTHR 18.86
- RS N/A
- EPS
- UTHR 25.10
- RS 14.01
- Revenue
- UTHR $2,994,100,000.00
- RS $13,674,900,000.00
- Revenue This Year
- UTHR $14.30
- RS $4.80
- Revenue Next Year
- UTHR $6.32
- RS $4.71
- P/E Ratio
- UTHR $11.62
- RS $22.06
- Revenue Growth
- UTHR 19.84
- RS N/A
- 52 Week Low
- UTHR $266.98
- RS $250.07
- 52 Week High
- UTHR $417.82
- RS $326.87
- Technical
- Relative Strength Index (RSI)
- UTHR 43.35
- RS 57.55
- Support Level
- UTHR $281.97
- RS $303.97
- Resistance Level
- UTHR $329.85
- RS $312.70
- Average True Range (ATR)
- UTHR 9.11
- RS 7.50
- MACD
- UTHR -3.44
- RS -0.17
- Stochastic Oscillator
- UTHR 29.04
- RS 78.29
About UTHR United Therapeutics Corporation
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.
About RS Reliance Steel & Aluminum Co. (DE)
Reliance Inc is a diversified metal solutions provider and metals service center company. It provides value-added metals processing services and distributes.